Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3805538 | 1.00 | HDAC1 (0.47) | HDAC1HDAC8MEN1KMT2ACYP1A2 | |
| SCHEMBL22446179 | 0.80 | SLC2A1 (0.42) | MEN1KMT2ACYP1A2TSHRHIF1A | |
| SCHEMBL9766296 | 0.79 | RIPK1 (0.51) | AOC3ALDH1A1LMNA | |
| SCHEMBL24115516 | 0.78 | HTR2A (0.40) | — | |
| SCHEMBL6600161 | 0.77 | SLC6A2 (0.44) | AOC3CYP2D6CYP3A4UGT2B7SLC6A2 | |
| SCHEMBL6595578 | 0.76 | CCR1 (0.38) | MEN1KMT2ACYP1A2TSHRHIF1A | |
| SCHEMBL13527885 | 0.75 | SIGMAR1 (0.44) | — | |
| SCHEMBL1520904 | 0.75 | RIPK1 (0.53) | AOC3ALDH1A1LMNA | |
| SCHEMBL27094502 | 0.75 | RIPK1 (0.53) | AOC3ALDH1A1LMNA | |
| SCHEMBL24115475 | 0.74 | HTR2A (0.42) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8492574-B2 | Methods for preparing dioranozinc compounds | CHARETTE ANDRE (CA) | 2013-07-23 | — | — | US | disclosed |
| US-8492574-B2 | Methods for preparing dioranozinc compounds | CHARETTE ANDRE (CA) | 2013-07-23 | — | — | US | disclosed |
| US-20100121089-A1 | Methods for preparing dioranozinc compounds | CHARETTE ANDRE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121089-A1 | Methods for preparing dioranozinc compounds | ZRANB2, PRMT1, RDX | HDAC1 1177/4885HDAC8 4225/4885MEN1 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.